Mikael Svensson

Professor of Applied Health Economics

I am a health economist and professor at the School of Public Health and Community Medicine at the University of Gothenburg in Sweden, and previously Professor in the Department of Pharmaceutical Outcomes & Policy at the University of Florida. My research focuses on economic evaluation in healthcare and public health, health technology assessment, and healthcare policy topics.

Mikael Svensson

Latest from Substack

Loading latest posts...

Current Research Projects

Research Team

Ben Harvey

Ben Harvey

Post-Doc

Daniel Pouragheli

Daniel Pouragheli

PhD Student

Thomas Lane

Thomas Lane

Research Assistant

Pedro Serra da Silva

Pedro Serra da Silva

Research Assistant

Phan Thuy Nhien Nguyen

Phan Thuy Nhien Nguyen

Master's Student

Most Recent Publications

Modeling the Budget Impact of Disease-Modifying Therapies in Infantile-Onset Spinal Muscular Atrophy

Sumaya Abuloha, Amie Goodin, Tianze Jiao, Manuela Corti and Mikael Svensson

Clinical Drug Investigation, 2026: in press.

Do U.S. cancer drug sales reflect clinical benefit? Evidence from solid tumor drugs from 2008 to 2022

Melissa Miri, Sumaya Abuloha, Shu Niu, Alaa Alshehri, Ben Harvey and Mikael Svensson

Journal of Cancer Policy, 2026: 48: 100723.

GuREx-MIH: cost-effectiveness analysis of extraction versus restorative treatment for first permanent molars affected by Molar-Incisor Hypomineralisation in 11-year-old Swedish children

Adnan Hajdarević, Emina Čirgić, Birgitta Jälevik, Agneta Robertson, Tobias Fagrell, Mikael Svensson and Nina Sabel

BMC Oral Health, 2026: 26: 126.

Optimizing Age-Based Targeting in Ice Cleat Distribution Programs for Preventing Winter Fall Injuries: A Cost-Effectiveness Modeling Study

Carl Bonander, Johanna Gustavsson, Ulf Strömberg and Mikael Svensson

Injury Epidemiology, 2025: 13: 76.

For a complete list of publications organized by topic, please visit my publications page or Google Scholar profile.

Policy & Advisory Roles

Beyond academia, I work at the intersection of health economics research and decision-making. My experience includes:

The Dental and Pharmaceutical Benefits Agency (TLV)

Member of the Board for Pharmaceutical Benefits, deciding on pharmaceutical reimbursement in Sweden.

Region Västra Götaland

Committee member for the Structured Implementation of Healthcare Technologies (ordnat införande).

Advisory & Consulting

Advisor on health economics, economic evaluation, and HTA to international agencies and payers.

Teaching

Courses

In the academic year 26/27 I teach a course on advanced health economic evaluation methods and direct the master's thesis course, both in the Master's Programme in Public Health Science at the University of Gothenburg.

Teaching Material

My textbook on economic evaluation in healthcare (Studentlitteratur, in Swedish).